期刊文献+

超敏C-反应蛋白测定对急性冠脉综合征危险分层的意义 被引量:3

下载PDF
导出
摘要 目的 :探讨超敏C 反应蛋白 (HS CRP)与急性冠脉综合征 (ACS)危险分层意义 ,并通过对ACS患者进行他汀类药物干预随访 ,以减少冠脉事件。方法 :采用散射比浊法测定 4 5例ACS患者和 6 2例非ACS患者HS CRP含量。并对ACS患者采用随机、对照方法分为他汀类药物治疗组 (2 2例 )和常规组 (2 3例 ) ,测定治疗前后 8周血清HS CRP含量。结果 :ACS组患者HS CRP浓度显著高于非ACS组 (P <0 .0 1) ,且浓度水平与冠脉病变程度有相关性。ACS组患者应用他汀类药物治疗 8周后HS CRP浓度下降有非常显著性 (P <0 .0 1)。结论 :血清HS CRP浓度与ACS病变程度有良好相关性 ,可作为一种新的危险因子应用于ACS危险分层评估。他汀类药物可阻止ACS患者冠脉病变的炎症反应。
出处 《临床医药实践》 2005年第1期36-37,共2页 Proceeding of Clinical Medicine
  • 相关文献

参考文献8

  • 1罗玮.普伐他汀对血浆C—反应蛋白浓度的长期作用[J].国外医学:心血管疾病分册,2002,29(2):118-118.
  • 2Mendall Ma,Patel P,Ballam L et al. Reactive protein and relation to ardiovascular risk factors:a population based cross sectional study[J]. Br Med J, 1996,312 (27): 1061~ 1065.
  • 3Anderson IL,Carlouist JF,Muhlestein JB et al. Evaluation of c-reactive protin,and inflammatory marker, and infections serology as fisk factors for coronary artery disease and myocardial infection[J]. J Am coll cardiol, 1998,32 (1): 35 ~ 41.
  • 4Rifal N, Rider PM. High sensitivity c-reactive protein:a novel and promising marker of coronary heart disease [J]. Clinical Chemistry, 2001,47: 403 ~ 411.
  • 5Ridker PM,Cushman M,Stampfer MJ et al. Inflammation,aspirin,and the risk of cardiovascular disease in apparently healthy men[J]. N EngL J Med, 1996,236:973.
  • 6Ridker PM,Hennekens CH,Buring JE et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women[J]. N Engl J Med,2000,342(12):836~843.
  • 7Kuller LH,Tracy RP,Shaten J et al. Relation of c-reactive protein and coronary heart disease in the MRFIT nested case-control study[J]. Am J Epidemiol,1996,144:537~547.
  • 8李为民,甘润韬.急性心肌梗死的诊断与治疗[J].中国实用内科杂志,2003,23(8):459-461. 被引量:65

二级参考文献7

  • 1Alpert J S, Thygesen K, Antman E, et al. Myocardial infarction redefined: a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol , 2000,36:959.
  • 2Feruson JL, Beckett GJ, Stoddart M, et al. Myocardial infarction redefined: the new ACC/ESC definition, based on cardiac troportia, increases the apparent incidence of infarction. Heart,2002,88(4) :343.
  • 3Meier MA, Albar WH, Cooper JV, et al. The new definition of myocardial infarction : diagnostic and prognostic implications in patients with acute coronary syndromes. Arch Intern Med, 2002,162(14): 1585.
  • 4Sousa E, Costa MA, Sousa A, et al. Two- year angiographic and intravascular ultrasound follow- up after implantation of sirolimus-eluting stents in human coronary arteries. Circulation, 2003,107:381.
  • 5Grube E , Silber S, Eugen HK, et al. Six- and twelve- month results from a randomized, double- blind trial on a slow- release paclitaxel - eluting stent for de novo coronary lesions. Circulation,2003,107 : 38.
  • 6Braunwald E, Antman EM, Califf RM, et al. Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina). Circulation, 2002, 106:1893.
  • 7潘柏申.心肌损伤标志物的研究进展与心肌梗死诊断标准的修订[J].临床检验杂志,2002,20(3):129-132. 被引量:138

共引文献74

同被引文献11

引证文献3

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部